Hubei Innerse Biotechnology Co., Ltd. is a CDMO (contract research and development production) enterprise that provides R&D and industrialization services for drug R&D and industrialization institutions in the field of small molecule chemical drugs. The company's existing business includes the R&D and production of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and green chemistry-related processes. The company's main products include: topical anti-inflammatory and disinfectant small molecule drugs Benvitimod/Tapinarof and related intermediates, hair growth products Kopexil and Kopyrrol and minoxidil and their intermediates, fluorescence dyes tracer D-fluorescein and sodium salt and potassium salt, cationic liposomes SM-102, Lipid 5, as well as fluorinated phenols, imidazole heterocyclic molecular building blocks. The company focuses on the sustainable development of global green chemistry, vigorously develops and promotes mobile chemical processes in the pharmaceutical, pesticide, and other fine chemical industries, and has newly built mobile chemical laboratories that adapt to different production capacities. In addition, it has supporting continuous flow microchannel reactor equipment and production workshops with an annual circulation of 2000 tons, which can realize one-stop service from process to equipment for mobile chemistry from small scale testing, pilot testing to commercial production.